We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has issued recommendations for health care providers and biomedical engineers to take additional safety steps beyond those issued by the manufacturer when using the COLLEAGUE Volumetric Infusion Pump manufactured by Baxter Healthcare Corporation.
The Centers for Medicare & Medicaid Services (CMS) has proposed a rule to lower Medicare costs for certain durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) by allowing competitive bidding among manufacturers, the agency announced April 24.
Cyberonics Inc., a medical devices manufacturer, raised its outlook for fourth quarter sales on increased demand for VNS, or vagus nerve stimulation, therapy among treatment resistant-depression patients and psychiatrists.
Xenomics, Inc., a developer of next-generation medical DNA diagnostic technologies, today announced that its research scientists have successfully identified DNA sequences of the H. pylori bacteria in the urine of infected patients.
Provectus Pharmaceuticals, Inc. announced today that it has received its fifth patent for its medical device technologies (U.S. Patent 7,036,516), bringing the total patents received to-date in the U.S. to fifteen.
St. Jude Medical, Inc. today announced U.S. Food and Drug Administration (FDA) approval, receipt of European CE Mark clearance and market launch of the QuickSite XL bipolar, left-heart lead to treat heart failure patients.
Multidetector computed tomography, or MDCT, a form of computed tomography technology for diagnostic imaging, can detect bladder tumors, say U.S. researchers.
Medtronic, Inc. has announced plans to increase significantly its investment in clinical trials of the company's neurological and urological therapies.
Regeneron Pharmaceuticals May 1 announced positive preliminary results from its Phase I trial of the Vascular Endothelial Growth Factor (VEGF) trap to treat patients with the neovascular form of age-related macular degeneration (AMD), or wet AMD.
Biophan Technologies has entered into a cooperative research and development agreement (CRADA) with the FDA to improve patient safety in magnetic resonance imaging (MRI) environments, the company
announced today.